William is an Executive Editor at Informa Pharma Intelligence with primary responsibility for biopharma industry-related coverage for its flagship feature-oriented online and monthly print publication, In Vivo. Principal areas of focus include global commercial strategy; C-suite issues and operations; market access; reputation; regulation and policy.
William is responsible for editorial content and serves as a thought leader in contacts between In Vivo and a wide variety of external organizations he has been involved with over the course of his career. Prior to joining In Vivo, he was Editor-in-Chief of Pharmaceutical Executive magazine, where he was recognized by the business media press for excellence in editorial commentary. He also served in industry as a Director at Pfizer Inc., managing the company's public policy issue development and positioning outside the US and coordinating various external leadership activities for the CEO. William began his career as a business analyst for the Economist Intelligence Unit of the UK Economist Group.
